Yuan Xiong - Director, Clinical Pharmacology and Pharmacometrics - The Janssen Pharmaceutical Companies of Johnson & Johnson | LinkedIn
![The Association Between Metabolic Status and Risk of Cancer Among Patients With Obesity: Metabolically Healthy Obesity vs. Metabolically Unhealthy Obesity - Frontiers The Association Between Metabolic Status and Risk of Cancer Among Patients With Obesity: Metabolically Healthy Obesity vs. Metabolically Unhealthy Obesity - Frontiers](https://www.frontiersin.org/files/MyHome%20Article%20Library/783660/783660_Thumb_400.jpg)
The Association Between Metabolic Status and Risk of Cancer Among Patients With Obesity: Metabolically Healthy Obesity vs. Metabolically Unhealthy Obesity - Frontiers
![Frontiers | Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease Frontiers | Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease](https://www.frontiersin.org/files/Articles/522637/fcvm-07-00022-HTML/image_m/fcvm-07-00022-g001.jpg)